{"product_id":"global-radioimmunotherapy-industry-research-report-growth-trends-and-competitive-analysis-2023-2029","title":"Global Radioimmunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2023-2029","description":"\u003cp\u003eGlobal Radioimmunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eDue to the COVID-19 pandemic, the global Radioimmunotherapy market size was US$ 1042.83 million in 2022 and is forecast to a readjusted size of US$ 4479 million by 2029 with a CAGR of 17.43% during the forecast period 2023-2029.\u003c\/p\u003e \n\n\u003cp\u003eThe global key companies of Radioimmunotherapy include Bayer, Novartis, Lantheus, Aurobindo Pharma, Mundipharma, China Isotope \u0026amp; Radiation, Curium Pharmaceuticals, and etc. In 2022, the global top five players hold a share approximately 99.25% in terms of revenue.\u003c\/p\u003e\n\n\u003cp\u003eThe United States Radioimmunotherapy market size was US$ 504.62 million in 2022, while China size was US$ 23.72 million. The proportion of the United States was 48.39% in 2022, while China percentage was 2.27%, and it is predicted that China share will reach 1.44% in 2029, trailing a CAGR of 20.26 % through the analysis period. As for the Europe Radioimmunotherapy landscape, Germany is projected to reach US$ 327 million by 2029.\u003c\/p\u003e \n\n\u003cp\u003eThe market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Radioimmunotherapy market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Radioimmunotherapy market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Radioimmunotherapy market. Readers of the report can become informed about current and future trends of the global Radioimmunotherapy market and how they will impact market growth during the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eBy Company\u003c\/p\u003e\n\n\u003cp\u003eOn Market\u003c\/p\u003e\n\n\u003cp\u003eBayer\u003c\/p\u003e\n\n\u003cp\u003eNovartis\u003c\/p\u003e\n\n\u003cp\u003eLantheus\u003c\/p\u003e\n\n\u003cp\u003eAurobindo Pharma\u003c\/p\u003e\n\n\u003cp\u003eMundipharma\u003c\/p\u003e\n\n\u003cp\u003eChina Isotope \u0026amp; Radiation\u003c\/p\u003e\n\n\u003cp\u003eCurium Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003eOn Pipeline\u003c\/p\u003e\n\n\u003cp\u003eGilead Sciences\u003c\/p\u003e\n\n\u003cp\u003eClarity Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003eCurasight\u003c\/p\u003e\n\n\u003cp\u003eNordic Nanovector\u003c\/p\u003e\n\n\u003cp\u003ePhilogen\u003c\/p\u003e\n\n\u003cp\u003eRadioMedix\u003c\/p\u003e\n\n\u003cp\u003eTelix Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003eOrano Med\u003c\/p\u003e\n\n\u003cp\u003eActinium Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003eY-mAbs Therapeutics\u003c\/p\u003e\n\n\u003cp\u003eFusion Pharmaceuticals\u003c\/p\u003e\n\n\u003cp\u003eSegment by Type\u003c\/p\u003e\n\n\u003cp\u003eBeta-emitting\u003c\/p\u003e\n\n\u003cp\u003eTargeted Alpha Therapy\u003c\/p\u003e\n\n\u003cp\u003eSegment by Application\u003c\/p\u003e\n\n\u003cp\u003eNon Hodgkin Lymphoma (NHL)\u003c\/p\u003e\n\n\u003cp\u003eSolid Tumor\u003c\/p\u003e\n\n\u003cp\u003eBy Region\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003c\/p\u003e\n\n\u003cp\u003eUnited States\u003c\/p\u003e\n\n\u003cp\u003eCanada\u003c\/p\u003e\n\n\u003cp\u003eAsia-Pacific\u003c\/p\u003e\n\n\u003cp\u003eChina\u003c\/p\u003e\n\n\u003cp\u003eJapan\u003c\/p\u003e\n\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\n\u003cp\u003eIndia\u003c\/p\u003e\n\n\u003cp\u003eSoutheast Asia\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n\u003cp\u003eGermany\u003c\/p\u003e\n\n\u003cp\u003eFrance\u003c\/p\u003e\n\n\u003cp\u003eU.K.\u003c\/p\u003e\n\n\u003cp\u003eItaly\u003c\/p\u003e\n\n\u003cp\u003eRussia\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003c\/p\u003e\n\n\u003cp\u003eMexico\u003c\/p\u003e\n\n\u003cp\u003eBrazil\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eMiddle East\u003c\/p\u003e \n\n\u003cp\u003eAfrica\u003cbr\u003e\n \u003cbr\u003e\nChapter Outline\u003c\/p\u003e\n\n\u003cp\u003eChapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.\u003c\/p\u003e\n\n\u003cp\u003eChapter 2: Revenue of Radioimmunotherapy in global and regional level.\u003c\/p\u003e\n\n\u003cp\u003eChapter 3: Detailed analysis of Radioimmunotherapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.\u003c\/p\u003e\n\n\u003cp\u003eChapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.\u003c\/p\u003e\n\n\u003cp\u003eChapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.\u003c\/p\u003e\n\n\u003cp\u003eChapter 6: North America (US \u0026amp; Canada) by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 7: Europe by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 8: Asia Pacific by Type, by Application and by region, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 9: Latin America by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 10: Middle East and Africa, by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radioimmunotherapy revenue, gross margin, and Business Strategy, etc.\u003c\/p\u003e\n\n\u003cp\u003eChapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.\u003c\/p\u003e\n\n\u003cp\u003eChapter 13: Research Findings and Conclusion\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"August, 2023 \/ 156 Pages \/ MCW16231559","offer_id":47647324242226,"sku":null,"price":6720.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-radioimmunotherapy-industry-research-report-growth-trends-and-competitive-analysis-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}